News, archive: April 2023
In Q1 2023, Russian manufactures produced 167.6 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 9.8% from Q1 2022. In physical terms, the production was 0.98 billion packages, down 10.3% from Q1 2022. If calculated in minimum dosage units (MDU), the production went down 3.9%, with 19.1 billion MDUs.
4/13/2023 Study by RNC Pharma and Medvestnik: 70% of Russian Doctors Want to Leave Public Healthcare Due to Low Salaries and Overwork, 30% Would Leave if Offered Decent Alternatives
39.6% of physicians think they could leave public healthcare in favor of a private medical institution due to “unjustifiably low salaries”, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. Another popular reason is “excessive workload and constant overwork”, voted by 31.3% of the respondents.
4/10/2023 Study by RNC Pharma and Medvestnik: 72% of Russian Doctors Want to Retrain, 21% Actually Plan to
While most Russian physicians would like to be able to have additional training in a narrower specialty, the options offered by the Ministry of Health are not suitable for 28.9%, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.